Quantcast

Posts related to ‘liver cancer’

Metabasis Escapes Biotech Zombiedom (MBRX)

Metabasis Therapeutics (NASDAQ:MBRX) announced after the close today that its MB07133 has been granted orphan medicinal product status for the treatment of hepatocellular carcinoma (primary liver cancer) by the European ...
Read Full Story »